Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cachexia: current insights and management

Jamie H Von Roenn

    Clinical Advances in Hematology & Oncology : H&O
    |September 17, 2005
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Advancing the Clinician Educator Career Pathway in Oncology.

    JCO oncology practice·2022
    Same author

    Critically Ill Patients' Preferences Regarding Aggressive Medical Interventions: Can We Hear the Patient's Voice?

    JAMA oncology·2015
    Same author

    Racial/Ethnic Differences in Inpatient Palliative Care Consultation for Patients With Advanced Cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2015
    Same author

    Reply to H.G. Muntz et al.

    Journal of oncology practice·2015
    Same author

    How well do medical oncologists manage chronic cancer pain? A national survey.

    The oncologist·2015
    Same author

    Under- or overtreatment of pain in the patient with cancer: how to achieve proper balance.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2014
    Same journal

    Clinical response with cabozantinib plus nivolumab, a first-line therapy in advanced renal cell carcinoma: a clinical case report.

    Clinical advances in hematology & oncology : H&O·2026
    Same journal

    Active treatment in high-risk, early-stage CLL or SLL.

    Clinical advances in hematology & oncology : H&O·2026
    Same journal

    Targeting human kallikrein 2 in prostate cancer.

    Clinical advances in hematology & oncology : H&O·2026
    Same journal

    Targeting BRAF V600E mutations in metastatic colorectal cancer.

    Clinical advances in hematology & oncology : H&O·2026
    Same journal

    The development of second-generation KRAS inhibitors.

    Clinical advances in hematology & oncology : H&O·2026
    Same journal

    Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.

    Clinical advances in hematology & oncology : H&O·2026
    See all related articles